Art

J-GLOBAL ID：200902242409919800   Reference number：09A1282601

Dose-Dependent Prognostic Effect of Carvedilol in Patients With Chronic Heart Failure Special Reference to Ranscardiac Gradient of Norepinephrine

慢性心不全患者におけるカルベジロールの用量に依存した予後効果 ノルアドレナリンの心臓横断勾配と特別な参照にして

Author (7)： NISHIYAMA Keizo (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.) ,  TSUTAMOTO Takayoshi (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.) ,  YAMAJI Masayuki (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.) ,  KAWAHARA Chiho (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.) ,  YAMAMOTO Takashi (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.) ,  FUJII Masanori (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.) ,  HORIE Minoru (Cardiovascular and Respiratory Medicine, Shiga Univ. of Medical Sci.)
Material： Circulation Journal  (Circ J)
Volume： 73  Issue： 12  Page： 2270-2275 (J-STAGE)  Publication year： 2009 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *chronic heart failure ,...
Semi thesaurus term： NT-proBNP ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A1282601&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (2)： Clinical application of cardioactive drugs  (GW07030Y) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Carvedilol ,  Norepinephrine

Reference (29)：

• 1. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-1355.
• 2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
• 3. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999; 353: 9-13.
• 4. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
• 5. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996; 94: 2807-2816.

Terms in the title (9)： 慢性心不全 ,  患者 ,  カルベジロール ,  用量 ,  予後 ,  ノルアドレナリン ,  心臓 ,  横断勾配 ,  参照